There are two major types of infectious vaccinia virus particles: mature virions (MVs) and enveloped virions (EVs). The MVs, which consist of a DNA-protein core surrounded by a lipoprotein membrane, are assembled in cytoplasmic viral factories and contain about 80 polypeptides. A subpopulation of MVs is wrapped by modified trans-Golgi or endosomal cisterna containing additional viral membrane proteins, transported along microtubules to the cell periphery, and exits the cell through the plasma membrane. The EVs are essentially MVs with an additional membrane that is disrupted prior to fusion of the MV with the cell during entry.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI001074-01
Application #
7732722
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
2008
Total Cost
$937,274
Indirect Cost
City
State
Country
United States
Zip Code
Bisht, Himani; Weisberg, Andrea S; Szajner, Patricia et al. (2009) Assembly and disassembly of the capsid-like external scaffold of immature virions during vaccinia virus morphogenesis. J Virol 83:9140-50
Satheshkumar, P S; Weisberg, Andrea; Moss, Bernard (2009) Vaccinia virus H7 protein contributes to the formation of crescent membrane precursors of immature virions. J Virol 83:8439-50
Domi, Arban; Weisberg, Andrea S; Moss, Bernard (2008) Vaccinia virus E2L null mutants exhibit a major reduction in extracellular virion formation and virus spread. J Virol 82:4215-26
Resch, Wolfgang; Hixson, Kim K; Moore, Ronald J et al. (2007) Protein composition of the vaccinia virus mature virion. Virology 358:233-47
Husain, Matloob; Weisberg, Andrea S; Moss, Bernard (2007) Sequence-independent targeting of transmembrane proteins synthesized within vaccinia virus factories to nascent viral membranes. J Virol 81:2646-55
Charity, James C; Katz, Ehud; Moss, Bernard (2007) Amino acid substitutions at multiple sites within the vaccinia virus D13 scaffold protein confer resistance to rifampicin. Virology 359:227-32